Literature DB >> 3035046

A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor.

D S Jessop, D Cunnah, J G Millar, E Neville, P Coates, I Doniach, G M Besser, L H Rees.   

Abstract

The case is described of a 61-year-old male who presented with hypertension and Cushing's syndrome which resolved on excision of a unilateral adrenal mass. Histology of the tumour revealed a benign phaeochromocytoma which immunostained for corticotrophin-releasing factor (CRF-41) but not for ACTH. Preoperative plasma concentrations of immunoreactive CRF-41 were increased, and gradients for both CRF-41 and ACTH were demonstrated across the tumour. Post-operatively, CRF-41 was undetectable in plasma. The tumour contained high concentrations of immunoreactive CRF-41 which co-eluted with synthetic human CRF-41 on reversed-phase high-performance liquid chromatography. Tumour CRF-41 stimulated the release of ACTH in a dose-dependent manner from isolated rat anterior pituitary cells. We conclude that this tumour secreted CRF-41 and ACTH and had the capacity to produce ACTH-dependent Cushing's syndrome directly by secreting ACTH and indirectly by secreting CRF-41 to stimulate ACTH secretion from the anterior pituitary.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035046     DOI: 10.1677/joe.0.1130133

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  ACTH-secreting pheochromocytoma with false-negative ACTH immunohistochemistry.

Authors:  Maria Francesca Cassarino; Alberto Giacinto Ambrogio; Luca Pagliardini; Martina De Martin; Valeria Barresi; Francesco Cavagnini; Francesca Pecori Giraldi
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

Review 2.  Ectopic cushing's syndrome due to corticotropin releasing hormone.

Authors:  Manouchehr Nakhjavani; Alireza Amirbaigloo; Soghra Rabizadeh; Fabio Rotondo; Kalman Kovacs; Ali A Ghazi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

3.  Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Adrenocortical atrophy of hypophysectomized rats can be reduced by corticotropin-releasing hormone (CRH).

Authors:  S R Bornstein; M Ehrhart; W A Scherbaum; E F Pfeiffer
Journal:  Cell Tissue Res       Date:  1990-04       Impact factor: 5.249

5.  Primary adrenal causes of Cushing's syndrome. Diagnosis and surgical management.

Authors:  R R Perry; L K Nieman; G B Cutler; G P Chrousos; D L Loriaux; J L Doppman; W D Travis; J A Norton
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

6.  Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma.

Authors:  M Terzolo; A Alì; A Pia; E Bollito; G Reimondo; P Paccotti; R Scardapane; A Angeli
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

Review 7.  Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature.

Authors:  Sadeka Shahani; Rodolfo J Nudelman; Ramaswami Nalini; Han-Seob Kim; Susan L Samson
Journal:  Diagn Pathol       Date:  2010-08-31       Impact factor: 2.644

8.  An unusual case of ectopic corticotrophin-releasing hormone syndrome caused by an adrenal noncatecholamine-secreting pheochromocytoma: a case report.

Authors:  Bao-Ping Wang; Lei-Lei Yang; Hao Wang; Qing He; Zhong-Shu Ma; Yi Lin; Chang-Xin Jiang; Hao-Ran Sun; Ming Liu
Journal:  BMC Endocr Disord       Date:  2018-06-19       Impact factor: 2.763

9.  Single-cell transcriptome analysis identifies a unique tumor cell type producing multiple hormones in ectopic ACTH and CRH secreting pheochromocytoma.

Authors:  Xuebin Zhang; Penghu Lian; Mingming Su; Zhigang Ji; Jianhua Deng; Guoyang Zheng; Wenda Wang; Xinyu Ren; Taijiao Jiang; Peng Zhang; Hanzhong Li
Journal:  Elife       Date:  2021-12-14       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.